SEC Form 4 · accession 0001127602-19-008322

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 22, 2019

Accepted (ET)

Feb 26, 2019 · 2:48 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Feb 14, 2019	G	3,575	$0.00	D	271,496	D
Common Stock^F1	Feb 22, 2019	A	16,357	$0.00	A	287,853	D
Common Stock	Feb 23, 2019	F	1,997	$144.67	D	285,856	D
Common Stock	Feb 24, 2019	F	2,212	$144.67	D	283,644	D
Common Stock	holding	—	—		—	18,390	I	2017 GRAT
Common Stock	holding	—	—		—	25,000	I	2018 GRAT
Common Stock	holding	—	—		—	10,000	I	Held By Spouse
Common Stock	holding	—	—		—	340	I	By Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)^F2	$144.67	Feb 22, 2019	A	69,743	A	Feb 22, 2020	Feb 22, 2024	Common Stock	69,743	69,743	D

F1Consists of 16,357 unvested restricted stock units that vest as follows: 4,089 shares vest one (1) year from the date of issuance, 4,089 shares vest two (2) years from the date of issuance, 4,089 shares vest three (3) years from the date of issuance, and 4,090 shares vest four (4) years from the date of issuance.
F2Stock options vest as follows: 17,435 options vest one (1) year from the date of grant, 17,436 options vest two (2) years from the date of grant, 17,436 options vest three (3) years from the date of grant, and 17,436 options vest four (4) years from the date of grant.